Livzon Pharma Convenes 24 Sep 2026 EGM to Approve Special Interim Dividend

Bulletin Express
Sep 08

Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a notice to convene its first Extraordinary General Meeting (EGM) of 2026 on 24 September 2026 at 2:00 p.m. in Zhuhai, Guangdong. The single agenda item is an ordinary resolution to approve a 2026 Special Interim Dividend for shareholders.

Key timetable • 18 Sep 2026 – Record date for determining shareholders entitled to attend and vote at the EGM. • 24 Sep 2026 – EGM date; exchange rate for HKD dividend conversion to be fixed at the PBOC RMB/HKD central parity rate on this date. • 13 Oct 2026 – Record date for A-share holders entitled to the Special Interim Dividend. • 15 Oct 2026 – Record date for H-share holders entitled to the Special Interim Dividend; deadline (4:30 p.m.) for lodging H-share transfer documents with Tricor Investor Services.

Dividend currency • A-share investors will receive the Special Interim Dividend in renminbi (RMB). • H-share investors will receive the dividend in Hong Kong dollars, converted from RMB at the 24 September 2026 PBOC central parity rate.

Tax treatment • Overseas individual H-shareholders: 20% individual income tax to be withheld by the company, in line with MOF and SAT Announcement 2026-No. 27. • Non-resident enterprise H-shareholders: 10% corporate income tax to be withheld under Guo Shui Han [2008] No. 897. • Southbound Trading Link investors: domestic individuals and securities investment funds subject to a 20% withholding; domestic enterprise investors to self-declare and pay taxes.

Shareholders may appoint one or more proxies to attend and vote, with proxy forms due 24 hours before the meeting. Completion of a proxy form does not preclude shareholders from attending the meeting in person.

Livzon Pharma’s board currently comprises two executive directors, three non-executive directors, one employee representative director, and four independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10